PlainRecalls
FDA Drug Critical Class I Terminated

Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50

Reported: September 4, 2013 Initiated: May 25, 2013 #D-920-2013

Product Description

Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50

Reason for Recall

Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
15,625 vials
Distribution
Nationwide
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50. Recalled by Fresenius Kabi USA, LLC. Units affected: 15,625 vials.
Why was this product recalled?
Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 4, 2013. Severity: Critical. Recall number: D-920-2013.